Why is Cachet Pharmaceutical Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -0.73% and Operating profit at -13.81% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 12.08% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -0.73% and Operating profit at -13.81% over the last 5 years
3
The company has declared Negative results for the last 4 consecutive quarters
- NET PROFIT(HY) At CNY -24.11 MM has Grown at -124.61%
- OPERATING CASH FLOW(Y) Lowest at CNY -138.6 MM
- ROCE(HY) Lowest at 3.02%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cachet Pharmaceutical Co., Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Cachet Pharmaceutical Co., Ltd.
-100.0%
0.89
31.20%
China Shanghai Composite
15.19%
1.01
15.10%
Quality key factors
Factor
Value
Sales Growth (5y)
-0.73%
EBIT Growth (5y)
-13.81%
EBIT to Interest (avg)
5.19
Debt to EBITDA (avg)
1.78
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
3.25
Tax Ratio
43.90%
Dividend Payout Ratio
30.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.34%
ROE (avg)
12.08%
Valuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
0.89
EV to EBIT
10.19
EV to EBITDA
8.60
EV to Capital Employed
0.90
EV to Sales
0.21
PEG Ratio
NA
Dividend Yield
1.27%
ROCE (Latest)
8.84%
ROE (Latest)
5.28%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
Technical Movement
3What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at 23.46 %
RAW MATERIAL COST(Y)
Fallen by -44.25% (YoY
-26What is not working for the Company
NET PROFIT(HY)
At CNY -24.11 MM has Grown at -124.61%
OPERATING CASH FLOW(Y)
Lowest at CNY -138.6 MM
ROCE(HY)
Lowest at 3.02%
INVENTORY TURNOVER RATIO(HY)
Lowest at 7.39%
NET SALES(Q)
Lowest at CNY 4,670.9 MM
Here's what is working for Cachet Pharmaceutical Co., Ltd.
Debt-Equity Ratio
Lowest at 23.46 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -44.25% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cachet Pharmaceutical Co., Ltd.
Net Profit
At CNY -24.11 MM has Grown at -124.61%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 4,670.9 MM has Fallen at -22.05%
over average net sales of the previous four periods of CNY 5,992.32 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY -138.6 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Net Sales
Lowest at CNY 4,670.9 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Inventory Turnover Ratio
Lowest at 7.39%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






